QQ客服 官方微博 反馈留言

	A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
	Zhi, Lu Ying[1]; Xu, Zhang[2]; Ning, Li[3]; Jin, Li Jia[4]; Cui, Yan Hai[5]; Hong, Huang Guan[6]; Fang, Xin Jian[7]
刊名	ONCOTARGETS AND THERAPY
	2018
卷号	11页码:5677-5688
关键词	CD44st TGF beta HER-2 invasion breast cancer
ISSN号	1178-6930
DOI	http://dx.doi.org/10.2147/OTT.S160531
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000444325500007
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5333083
专题	江苏大学
作者单位	1.[1]Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Med Oncol, 41 Hailian East Rd, Lianyungang 222000, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Med Coll, Mol Biol Lab, Zhenjiang 2012013, Jiangsu, Peoples R China. 3.[3]First Peoples Hosp Lianyungang, Dept Surg, Lianyungang 222000, Jiangsu, Peoples R China. 4.[4]Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Med Oncol, 41 Hailian East Rd, Lianyungang 222000, Jiangsu, Peoples R China. 5.Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 2, Dept Informat Ctr, Lianyungang 222000, Jiangsu, Peoples R China. 6.[5]Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Med Oncol, 41 Hailian East Rd, Lianyungang 222000, Jiangsu, Peoples R China. 7.[6]Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Med Oncol, 41 Hailian East Rd, Lianyungang 222000, Jiangsu, Peoples R China. 8.[7]Bengbu Med Coll, Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Med Oncol, 41 Hailian East Rd, Lianyungang 222000, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Zhi, Lu Ying[1],Xu, Zhang[2],Ning, Li[3],et al. A correlation study of the expression of HA-CD44st and HER-2 in breast cancer[J]. ONCOTARGETS AND THERAPY,2018,11:5677-5688.
APA	Zhi, Lu Ying[1].,Xu, Zhang[2].,Ning, Li[3].,Jin, Li Jia[4].,Cui, Yan Hai[5].,...&Fang, Xin Jian[7].(2018).A correlation study of the expression of HA-CD44st and HER-2 in breast cancer.ONCOTARGETS AND THERAPY,11,5677-5688.
MLA	Zhi, Lu Ying[1],et al."A correlation study of the expression of HA-CD44st and HER-2 in breast cancer".ONCOTARGETS AND THERAPY 11(2018):5677-5688.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。